Medical Health & Life Science Research News

Explore onychomycosis pipeline market for therapeutics H2 2017

Onychomycosis Pipeline (Tinea Unguium) Review, H2 2017 is a new Infectious Disease report includes 67 pages and Table of Content, List Tables and List of Figures.

- Agency -.

Onychomycosis Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Onychomycosis (Dermatology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Access Complete Report On Onychomycosis Pipeline Review, H2 2017: www.reportsnreports.com/purchase.aspx?name=1132634 .

- Agency -.

Onychomycosis is a chronic fungal infection of the nails caused by dermatophytes. Symptoms include thickened nail that is difficult to cut, brittle or ragged nail, discolored or unsightly nail and pain of the finger or toe with ordinary activities.

Treatment includes antifungal medications and surgery.

Get Onychomycosis - Pipeline Review, H2 2017 @ www.reportsnreports.com/contacts/d…aspx?name=1132634 .

The Onychomycosis (Tinea Unguium) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Onychomycosis (Tinea Unguium) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Preclinical, Discovery and Unknown stages are 1, 2, 6, 3, 3 and 1 respectively.

Scope

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages. The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities.

The report reviews key players involved Onychomycosis therapeutics and enlists all their major and minor projects. The report assesses Onychomycosis therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

The report summarizes all the dormant and discontinued pipeline projects. The report reviews latest news related to pipeline therapeutics for Onychomycosis

List of Figures
Number of Products under Development for Onychomycosis (Tinea Unguium), H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products by Top 10 Targets, H2 2017
Number of Products by Stage and Top 10 Targets, H2 2017
Number of Products by Mechanism of Actions, H2 2017
Number of Products by Stage and Mechanism of Actions, H2 2017
Number of Products by Routes of Administration, H2 2017
Number of Products by Stage and Routes of Administration, H2 2017
Number of Products by Molecule Types, H2 2017
Number of Products by Stage and Molecule Types, H2 2017

News From

ReportsnReports - Industry Trends & ForecastsReportsnReports
Category: Market Research Publishers and RetailersCompany profile: ReportsnReports.com provides market research reports to industries, individuals and organizations with an objective of helping them in their decision-making process. Our library of 400,000+ industry & country research reports covers 5000+ micro markets.